Glenmark Pharmaceuticals Share price target & analyst calls
₹2,194.1-16.10 (-0.73%)
As of 21 Oct 2026
Avg 1-year target
4 of 5 long-term calls BUY₹2,347.57.0% above today's price
Glenmark Pharmaceuticals' average 1-year share price target is ₹2,347.5, the average of 4 advisors' latest targets. Targets range from ₹1,640 to ₹2,590.
Latest: Jefferies India ₹2,590 · 4 Aug 2026
9
8 BUY · 1 SELL, all horizons
4
with an active 1Y target
32%
24 of 75 closed calls hit
85
all horizons, open and closed
Watch GLENMARK for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Glenmark Pharmaceuticals target price by brokerage
Each advisor's latest 1-year target · 4 advisors · tap a row for the call
All tips (85)
JIbyJefferies India+18.0% to target
1 Year* · 10 mo left · 4 Aug 2026 · entry ₹2,238 · via NDTV ProfitP&L -2.0%
HSbyHSBC Securities+18.0% to target
1 Year* · 10 mo left · 4 Aug 2026 · entry ₹2,238 · via CNBC Awaaz.P&L -2.0%
MObyMotilal Oswal+17.1% to target
1 Year* · 10 mo left · 3 Aug 2026 · entry ₹2,230 · via Institutional / Brokerage ResearchP&L -1.6%
MObyMotilal Oswal+19.0% to target
1 Year* · 7 mo left · 1 Jun 2026 · entry ₹2,201.2 · via Institutional / Brokerage ResearchP&L -0.3%
ISbyICICI Securities+25.3% to target
1 Year* · 4 mo left · 3 Feb 2026 · entry ₹1,954.2 · via Institutional / Brokerage ResearchP&L -12.3%
MObyMotilal OswalTarget hit
1 Year* · 2 Feb 2026 · entry ₹1,920.4 · via Institutional / Brokerage Researchexit ₹2,240
MObyMotilal OswalTarget hit
1 Year* · 17 Nov 2025 · entry ₹1,868.9 · via Institutional / Brokerage Researchexit ₹2,170
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 2 Sept 2025 · entry ₹1,918.8 · via Institutional / Brokerage Researchexit ₹2,300
MObyMotilal OswalTarget hit
1 Year* · 18 Aug 2025 · entry ₹1,973.9 · via Institutional / Brokerage Researchexit ₹2,400
MObyMotilal OswalTarget hit
1 Year* · 11 Jul 2025 · entry ₹2,181.1 · via Institutional / Brokerage Researchexit ₹2,430
MObyMotilal OswalTarget hit
1 Year* · 26 May 2025 · entry ₹1,390.1 · via Institutional / Brokerage Researchexit ₹1,690
ISbyICICI SecuritiesTarget hit
1 Year* · 16 Aug 2024 · entry ₹1,565.8 · via Institutional / Brokerage Researchexit ₹1,345
MObyMotilal OswalTarget hit
1 Year* · 16 Aug 2024 · entry ₹1,565.8 · via Institutional / Brokerage Researchexit ₹1,850
ISbyICICI SecuritiesExpired
1 Year* · 19 Aug 2025 · entry ₹1,945.8 · via Institutional / Brokerage Researchexit ₹2,246.5
ISbyICICI SecuritiesExpired
1 Year* · 18 Jul 2025 · entry ₹2,225.5 · via Institutional / Brokerage Researchexit ₹2,235.5
RSbyRahul Sharma, JM Financial+18.5% to target
1–3 Months · 2 mo left · 23 Sept 2026 · entry ₹2,464.4 · via CNBC Awaaz.P&L -11.0%
CBbyChoice Broking+18.0% to target
1–3 Months* · 4 wk left · 20 Aug 2026 · entry ₹2,331 · via Economic Times Stock Recos OverviewP&L -5.9%
RSbyRahul Sharma, JM FinancialTarget hit
1–3 Months · 29 Jun 2026 · entry ₹2,180 · via CNBC Awaaz.exit ₹2,380
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–3 Months* · 6 Aug 2026 · entry ₹2,277.6 · via CNBC Awaaz.exit ₹2,245
ICbyIDBI CapitalStop-loss hit
1–3 Months · 23 Jun 2026 · entry ₹2,214 · via IDBI Capital Research Calls Telegramexit ₹2,161
RJbyRuchit Jain, Motilal OswalStop-loss hit
1–3 Months · 30 Mar 2026 · entry ₹2,131.7 · via ET Nowexit ₹2,030
SMbySomil Mehta, Sharekhan+9.4% to target
1–2 Weeks* · 12d left · 19 Oct 2026 · entry ₹2,229.7 · via Zee Business (Live)P&L -1.6%
OKbyOsho Krishan, Angel One+9.4% to target
1–2 Weeks* · 6d left · 13 Oct 2026 · entry ₹2,261.4 · via ET Now (Live)P&L -3.0%
KBbyKush BohraTarget hit
1–2 Weeks* · 5 Oct 2026 · entry ₹2,312.2 · via NDTV Profit (Live)exit ₹2,320
ABbyAshish Bahety, Profitmart SecuritiesTarget hit
1–2 Weeks* · 26 Aug 2026 · entry ₹2,392.2 · via CNBC Awaaz.exit ₹2,450
NCbyNirav Chheda, Nirmal Bang SecuritiesTarget hit
1–2 Weeks* · 24 Aug 2026 · entry ₹2,365.5 · via Zee Business (Live)exit ₹2,450
CTbyChandan Taparia, Motilal OswalTarget hit
1–2 Weeks* · 21 Aug 2026 · entry ₹2,334.6 · via LiveMint Marketsexit ₹2,470
SCbyShrikant Chouhan, Kotak SecuritiesTarget hit
1–2 Weeks* · 21 Aug 2026 · entry ₹2,334.6 · via Zee Business (Live)exit ₹2,420
SRbySiddharth Rai MangalaTarget hit
1–2 Weeks* · 11 Aug 2026 · entry ₹2,285 · via Zee Business (Live)exit ₹2,340
NSbyNagaraj Shetty, HDFC SecuritiesTarget hit
1–2 Weeks* · 13 Apr 2026 · entry ₹2,205 · via ET Nowexit ₹2,310
CTbyChandan Taparia, Motilal OswalTarget hit
1–2 Weeks* · 30 Mar 2026 · entry ₹2,120 · via ET Nowexit ₹2,230
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks · 23 Sept 2026 · entry ₹2,474 · via CNBC Awaaz.exit ₹2,445
AMbyAjit Mishra, ReligareStop-loss hit
1–2 Weeks · 9 Sept 2026 · entry ₹2,486.9 · via NDTV Profit (Live)exit ₹2,420
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 20 Aug 2026 · entry ₹2,334.6 · via ET Nowexit ₹2,310
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 14 Aug 2026 · entry ₹2,315 · via ET Now (Live)exit ₹2,275
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 12 Aug 2026 · entry ₹2,300 · via ET Now (Live)exit ₹2,230
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 30 Jul 2026 · entry ₹2,270.2 · via Business Todayexit ₹2,220
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Full call history, all horizons: page 2 of 2
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.1% · 19 calls
- CIPLACipla Ltd.₹1,524+16.0% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+27.5% · 15 calls
- BIOCONBiocon Ltd₹485+44.8% · 12 calls
- LUPINLupin Limited₹2,576+31.2% · 12 calls
- GLENMARK· this stockGlenmark Pharmaceuticals₹2,348+7.0% · 5 calls